Home / Tag Archives: VKTX

Tag Archives: VKTX

Healthcare News Buzz: Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX)

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, recently declared the appointment of Charles A. Rowland Jr. to its board of directors. With more than 30 years of biopharmaceutical industry experience, Mr. Rowland provides Viking with …

Read More »